News
Pharmaceutical Technology on MSN10h
Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugsDeep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.
Novo Nordisk (NVO) plans to start a late-stage clinical program next year to test oral and injectable forms of its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback